³Ô¹ÏÍøÕ¾

Latest drug development News

Nearly 80 million SEK to OnkPat researchers from the Swedish Cancer Society
Helping hand for WA’s health and medical life sciences sector
Leukaemia Foundation and HSANZ funding next generation of clinicians and researchers to save more Australian lives
Potential drugs for cancer treatment may help tackle tuberculosis
Ardena Expands Bioanalytical Services in Europe
Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences Industry
Antifungal resistance is not getting nearly as much attention as antibiotic resistance – yet the risks to global health are just as serious
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent…
Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent
The Nobel Prize in Chemistry helps us understand the building blocks of life
Machine learning cracked the protein-folding problem and won the 2024 Nobel Prize in chemistry
The medicines we take to stay healthy are harming nature. Here’s what needs to change
New Theory Demystifies Crystallization Process
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
Accelerating Pioneering Inflammatory Diseases Research
Drug Testing Evolved
New Centre To Be Key In Global AI Medical Research
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
Brandon BioCatalyst’s CUREator Incubator Boosts Preclinical and Health Security Biotech Innovations with $1.865 million in funding
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
Noxopharm reports results from Chroma platform drug development program
€1.3M Pre-seed Funding For Lucid Genomics
Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)
New Chemical Tool Developed For Infection Research
Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of…
Rwanda team visits Addis Ababa for clinical trial training
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
Noxopharm targets clinical trial for first-in-class investigative therapy
AusBioInvest 2024 Keynote Speaker Announced
New Tool PISA-REX Facilitates Drug Development
FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face
AI accelerates the pace of development of new drugs for brain diseases
Personalised cancer vaccines to be produced at new UQ lab
Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face
Conformational dynamics and allostery elucidate how GPCR couple to multiple G-proteins, offering mechanistic insights into coupling-promiscuity and novel drug discovery strategies
T-cells With License To Kill Viruses
Supercharging Queensland’s Drug Discovery Pipeline
Personalised cancer vaccines to be produced at new UQ lab
NSW Government invests $4.5 million to help reduce and replace animals in medical research
PsiQuantum partners with Queensland universities to advance quantum computing in Australia
Research to make lithium safer for BD patients
NIH Funds Consortium To Speed TB Treatment Development
New Medicines Manufacturing Innovation Centre opens: Monash accelerates medical innovation and development of life-saving treatments
TeraPore uses Cornell research to address virus filtration challenges
Psylo partnership to deliver psychedelic treatments for mental health
DoD grant to fund prostate cancer bone metastases research
Robots Face Future
Childhood cancer detectives embrace open-source AI solution